Instructions Furacilin tablets for preparation of solution for external use 20 mg blister No. 20
Composition
active ingredient: 1 tablet contains nitrofurazone (nitrofural), calculated as 100% substance – 20 mg;
Excipients: sodium chloride, croscarmellose sodium, povidone, stearic acid.
Dosage form
Tablets for preparation of solution for external use.
Main physicochemical properties: tablets of yellow or greenish-yellow color, with slightly uneven surface color, flat-cylindrical shape, with a chamfer and a score.
Pharmacotherapeutic group
Antiseptics and disinfectants. ATX code D08AF01.
Pharmacological properties
Pharmacodynamics.
Nitrofural belongs to antibacterial agents. It is a strong antiseptic, active against staphylococci, streptococci, dysentery and Escherichia coli, salmonella, and gas gangrene pathogens. Promotes granulation and wound healing processes. The mechanism of action of the drug is associated with its ability to restore the nitro group to the amino group, disrupt DNA function, and inhibit cellular respiration of microorganisms.
Indication
Mouth and throat rinsing, purulent wounds, bedsores, ulcerative lesions, second and third degree burns, osteomyelitis, pleural empyema, chronic purulent otitis, anaerobic infections.
Contraindication
Hypersensitivity to the drug and to other nitrofuran derivatives, allergic dermatoses.
Special safety precautions
The drug is intended for external use only!
Interaction with other medicinal products and other types of interactions
Not studied.
Use during pregnancy or breastfeeding
There is no experience with the use of the drug during pregnancy or breastfeeding.
Ability to influence reaction speed when driving vehicles or other mechanisms
Not studied.
Method of administration and doses
Furacilin is applied externally, in the form of an aqueous 0.02% (1:5000) solution. To prepare an aqueous solution, dissolve 1 tablet in 100 ml of isotonic sodium chloride solution or distilled water (for quick dissolution, use hot water). After that, cool the solution to room temperature and store for a long time (sterilization for 30 minutes at 100 °C).
Mouth and throat rinse: dissolve 20 mg (1 tablet) in 100 ml of hot water.
Repeat the rinse according to the doctor's recommendations. The course of treatment depends on the form and severity of the disease, the nature of concomitant therapy, the achieved effect of treatment and is determined by the doctor individually, but should not exceed 10 days.
For purulent wounds, bedsores, ulcerative lesions, second and third degree burns, to prepare the granulating surface for skin grafting and secondary suture, irrigate the wound with an aqueous solution of Furacilin and apply wet bandages.
After surgery for osteomyelitis, rinse the cavity with an aqueous solution of Furacilin, then apply a wet bandage.
In case of pleural empyema, aspirate the pus, wash the pleural cavity using a standard method. Then inject 20-100 ml of an aqueous solution of the drug into the pleural cavity.
In case of anaerobic infection, after standard surgical intervention, the wound should also be treated with Furacilin.
In chronic purulent otitis, 8-10 drops of an aqueous solution of Furacilin should be applied to a cotton swab or turunda and inserted into the external auditory canal 2 times a day. The solution should be warmed to body temperature beforehand.
Children
There is no experience with the use of the drug in children (under 18 years of age), therefore it should not be prescribed to patients in this age category.
Overdose
When using large doses of the drug, side effects may increase.
Adverse reactions
When used externally, Furacilin is usually well tolerated. Sometimes dermatitis may occur, and when gargling, irritation of the oral mucosa may occur, which requires temporary discontinuation of the drug.
In some cases, when using the drug, the following are possible:
On the part of the immune system: allergic reactions, including itching, hyperemia, skin rashes; very rarely - angioedema.
Expiration date
5 years.
Storage conditions
Store in the original packaging at a temperature not exceeding 25 °C.
Keep out of reach of children.
Packaging
Tablets No. 10 in a blister; No. 10 in a blister, 2 blisters in a pack.
Vacation category
Without a prescription.
Producer
PJSC "Kyivmedpreparat" or PJSC "Galychpharm".
Location of the manufacturer and its business address
Ukraine, 01032, Kyiv, Saksaganskoho St., 139 or
Ukraine, 79024, Lviv, Opryshkivska St., 6/8.
